We are live on ! Find out more
PKBO

Peak Bio, Inc. Common Stock
PKBO

Delisted

PKBO was delisted on the 9th of January, 2023.

Back to rankings

36 hedge funds and large institutions have $34.3M invested in Peak Bio, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

20% more funds holding

Funds holding: 30 → 36 (+6)

3% more capital invested

Capital invested by funds: $33.4M → $34.3M (+$957K)

Holders
36
Holders Change
+6
Holders Change %
+20%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$747K
2
AA
AQR Arbitrage
Connecticut
+$342K
3
Walleye Capital
Walleye Capital
New York
+$215K
4
CFIA
Cantor Fitzgerald Investment Advisors
New York
+$157K
5
HIH
HRS Investment Holdings
New York
+$157K

Top Sellers

Rank Fund Capital Flow
1
KIM
Karpus Investment Management
New York
-$166K
2
WAM
Wolverine Asset Management
Illinois
-$59.7K
3
Millennium Management
Millennium Management
New York
-$59.2K
4
Citadel Advisors
Citadel Advisors
Florida
-$6.55K
5
PC
Periscope Capital
Ontario, Canada
-$1.96K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$7.06M – – –
KPF
2
K2 Principal Fund
Ontario, Canada
$4.02M – – –
SCM
3
Saba Capital Management
New York
$2.27M +$105K +10,693 +5%
DKCM
4
Davidson Kempner Capital Management
New York
$2.19M – – –
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$1.95M – – –
PC
6
Periscope Capital
Ontario, Canada
$1.46M -$1.96K -200 -0.1%
KIM
7
Karpus Investment Management
New York
$1.35M -$166K -17,000 -11%
WRBC
8
W.R. Berkley Corp
Connecticut
$1.12M – – –
BCM
9
Basso Capital Management
Connecticut
$1.11M – – –
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$1.08M +$747K +76,407 +222%
Citadel Advisors
11
Citadel Advisors
Florida
$1.08M -$6.55K -670 -0.6%
BFM
12
Boothbay Fund Management
New York
$986K – – –
ASM
13
ATW SPAC Management
New York
$974K – – –
RCM
14
Radcliffe Capital Management
Pennsylvania
$974K – – –
CM
15
Cohanzick Management
New York
$816K +$97.8K +10,000 +14%
PAMP
16
Polar Asset Management Partners
Ontario, Canada
$730K – – –
Jane Street
17
Jane Street
New York
$559K +$293 +30 +0.1%
DFCM
18
Dark Forest Capital Management
Puerto Rico
$479K +$137K +14,031 +40%
Millennium Management
19
Millennium Management
New York
$422K -$59.2K -6,048 -12%
CH
20
CVI Holdings
Delaware
$390K – – –
PMAM
21
Picton Mahoney Asset Management
Ontario, Canada
$390K – – –
LCM
22
Landscape Capital Management
New Jersey
$364K +$5.87K +600 +2%
WAM
23
Wolverine Asset Management
Illinois
$347K -$59.7K -6,098 -15%
AA
24
AQR Arbitrage
Connecticut
$341K +$342K +35,000 New
BI
25
Bulldog Investors
New Jersey
$244K – – –
1
2

PKBO Hedge Fund Activity: Q4 2021 in Review

36 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Peak Bio, Inc. Common Stock (PKBO) for Q4 2021, worth a combined $34.3M — up 2.9% from $33.4M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new PKBO positions and 0 closed out — a net gain of 6 holders — while 7 added to existing stakes and 5 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $747K. The largest seller was Karpus Investment Management, cutting an estimated $166K.

  • 36 institutional investors held Peak Bio, Inc. Common Stock (PKBO) as of Q4 2021, up from 30 in Q3 2021.
  • Funds reported $34.3M of Peak Bio, Inc. Common Stock stock for Q4 2021, up 2.9% quarter-over-quarter.
  • 6 funds opened new Peak Bio, Inc. Common Stock positions in Q4 2021 and 0 closed out, a net change of +6 holders.
  • The largest Peak Bio, Inc. Common Stock buyer in Q4 2021 was D.E. Shaw & Co, an estimated $747K added.
  • The largest Peak Bio, Inc. Common Stock seller in Q4 2021 was Karpus Investment Management, an estimated $166K sold.

Based on aggregated 13F filings for Q4 2021.